How to build an effective protein degrader

March 31, 2021

Working in PROTACs, you’re tasked with the most challenging targets — that aim to address intractable diseases such as cancer, Alzheimer's, or Parkinson's disease. Despite the impressive promise of PROTACs, you still have to overcome many hurdles in order to work with these difficult targets.

This guide highlights the four major stages of targeted protein degradation, the challenges at each step, and questions you should ask yourself to make sure your final product will result in a complete protein degradation.

Download this guide to learn:

  • What are the most common roadblocks at key stages in PROTAC development
  • What methods and technologies help you overcome these challenges
  • What outcomes you should expect at each stage
Previous Article
8 Targeted Protein Degradation conferences in 2023 you won’t want to miss
8 Targeted Protein Degradation conferences in 2023 you won’t want to miss

2023 is expected to be a year of big announcements in the targeted protein degradation (TPD) therapeutics s...

Up next
Put your challenging affinity screening campaigns back on track — after you’ve tried everything else
Put your challenging affinity screening campaigns back on track — after you’ve tried everything else

When you’re entrusted with developing therapeutics for challenging or undruggable targets, it’s a struggle ...

Want to see more
PROTACs content?

Explore resources